DBV Technologies SA
(OTCPK:DBVTF)
$
4.26
(0%)
Market Cap: 950.37 Mil
Enterprise Value: 727.27 Mil
PE Ratio: 0
PB Ratio: 4.61
GF Score: 27/100 
DBV Technologies SA at Barclays Global Healthcare Conference Transcript
Mar 13, 2019 / 02:45PM GMT
Release Date Price:
$10.16
Geoffrey Christopher Meacham
Barclays Bank PLC, Research Division - MD & Senior Research Analyst
(technical difficulty) I'm the senior biopharma analyst here at the firm. I have Scott Puckhaber from my team on stage with me as well. So we're excited to have DBV Technologies here on stage for a fireside chat. Its Chief Commercial Officer, Kevin Trapp; and Chief Business Officer Susanna Mesa.
Susanna Mesa
DBV Technologies S.A. - Chief Business Officer
Thank you.
Kevin Trapp
DBV Technologies S.A. - Chief Commercial Officer
Hey Geoff, Thanks for having us.
Geoffrey Christopher Meacham;Kevin Trapp
Barclays Bank PLC, Research Division - MD & Senior Research Analyst;DBV Technologies
Welcome guys. Yes, of course. So we've got a lot of questions here, but maybe just if you want to kick it off for maybe some of the audience that aren't as familiar just a kind of a 2 minute, kind of, background, and then we will get right in the question.
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers